Influence of disease location on vedolizumab efficacy in inflammatory bowel disease: a real-life multicentre experience

被引：0
|
作者：
Pestour, S. [1 ]
Nancey, S. [2 ]
Charlois, A. L. [2 ]
Bonaz, B. [1 ]
Flourie, B. [2 ]
Boschetti, G. [2 ]
Mathieu, N. [1 ]
机构：
[1] Grenoble Alpes Univ Hosp, Univ Clin Hepatogastroenterol, Grenoble, France
[2] Lyon Sud Univ Hosp, Dept Gastroenterol, Lyon, France
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP050
引用
收藏
页码：S65 / S66
页数：3
相关论文
共 50 条
  • [1] Efficacy and safety of vedolizumab in inflammatory bowel disease: Real-life experience
    Gonzalez Munoza, C.
    Mesonero, F.
    Bargallo, A.
    Clos, A.
    Arajol, C.
    Gordillo, J.
    Lopez-San Roman, A.
    Guardiola, J.
    Navarro-Llavat, M.
    Bertoletti, F.
    Fernandez, C.
    Domenech, E.
    Garcia-Planella, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S486 - S486
  • [2] Efficacy of Vedolizumab as Induction Therapy for Inflammatory Bowel Disease in a 'real-life' Study
    Trefois, Quentin
    Descamps, Olivier
    Coche, Jean-Charles
    Schapira, Michael
    [J]. ACTA CLINICA BELGICA, 2016, 71 : 7 - 7
  • [3] Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort study
    Bor, Renata
    Fabian, Anna
    Matuz, Maria
    Szepes, Zoltan
    Farkas, Klaudia
    Miheller, Pal
    Szamosi, Tamas
    Vincze, Aron
    Rutka, Mariann
    Szanto, Kata
    Balint, Anita
    Nagy, Ferenc
    Milassin, Agnes
    Toth, Tibor
    Zsigmond, Ferenc
    Bajor, Judit
    Mullner, Katalin
    Lakner, Lilla
    Papp, Maria
    Salamon, Agnes
    Horvath, Gabor
    Sarang, Krisztina
    Schafer, Eszter
    Sarlos, Patricia
    Palatka, Karoly
    Molnar, Tamas
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (02) : 205 - 213
  • [4] The real-life experience of vedolizumab efficacy and safety in Crohn's disease: a prospective observational multicentre cohort study
    Amiot, A.
    Grimaud, J. C.
    Treton, X.
    Filippi, J.
    Pariente, B.
    Peyrin-Biroulet, L.
    Noureille, A.
    Buisson, A.
    Carbonnel, F.
    Bourrier, A.
    Nancey, S.
    Roblin, X.
    Marteau, P.
    Altwegg, R.
    Moreau, J.
    Aubourg, A.
    Savoye, G.
    Pelletier, A. L.
    Fumery, M.
    Bonaz, B.
    Bouhnik, Y.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S313 - S314
  • [5] VEST: The UK vedolizumab real life experience study in Inflammatory Bowel Disease
    Bodger, K.
    Booker, C.
    Kok, K.
    Lobo, A.
    Ahmad, T.
    Bloom, S.
    Butterworth, J.
    Irving, P.
    Cummings, F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1775 - I1777
  • [6] Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina
    Salkic, Nermin
    Denjagic, Mirela Basic
    Zubcevic, Nada
    Tamburic, Renata
    Husic Selimovic, Azra
    Babic, Emil
    Bevanda, Milenko
    Saray, Aida
    Jovanovic, Predrag
    Tosic, Zoran
    Dobrovoljski, Aleksandar
    Barac, Tatjana
    [J]. BIOMOLECULES AND BIOMEDICINE, 2024, 24 (05): : 1400 - 1406
  • [7] Vedolizumab for inflammatory bowel disease: from randomized controlled trials to real-life evidence
    Scribano, Maria Lia
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (23) : 2457 - 2467
  • [8] Vedolizumab for inflammatory bowel disease:from randomized controlled trials to real-life evidence
    Maria Lia Scribano
    [J]. World Journal of Gastroenterology, 2018, (23) : 2457 - 2467
  • [9] Real World Experience of Vedolizumab in Pediatric Inflammatory Bowel Disease
    Whitney, Annette
    Sarles, Harry E., Jr.
    Claudia, Schroeder P.
    Okoro, Tracy C.
    Van Anglen, Lucinda J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S396 - S396
  • [10] Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice
    Ylisaukko-oja, Tero
    Torvinen, Saku
    Aaltonen, Jaakko
    Nuutinen, Heikki
    Blomster, Timo
    Jussila, Airi
    Pajala, Markku
    Salminen, Kimmo
    Moilanen, Veikko
    Hakala, Kalle
    Kellokumpu, Mikko
    Toljamo, Kari
    Rautiainen, Henna
    Kuisma, Juha
    Peraaho, Markku
    Molander, Pauliina
    Silvennoinen, Jouni
    Liukkonen, Ville
    Henricson, Hans
    Tillonen, Jyrki
    Esterinen, Mirva
    Nielsen, Christian
    Hirsi, Eija
    Laane, Margus
    Suhonen, Ulla-Maija
    Vihriala, Ilkka
    Makela, Petri
    Puhto, Mika
    Punkkinen, Jari
    Sulonen, Hannu
    Herrala, Sauli
    Jokelainen, Jari
    Tamminen, Klaus
    Sipponen, Taina
    [J]. BIOLOGICALS, 2019, 58 : 50 - 56
12345